Jasper Therapeutics Inc (NASDAQ: JSPR) kicked off on Monday, up 6.55% from the previous trading day, before settling in for the closing price of $1.68. Over the past 52 weeks, JSPR has traded in a range of $1.56-$26.05.
Over the past five-year period, the growth rate of yearbook sales for the company of the Healthcare sector was 54.53%. While this was happening, its average annual earnings per share was recorded 13.33%. With a float of $25.65 million, this company’s outstanding shares have now reached $27.98 million.
Jasper Therapeutics Inc (JSPR) Insider Activity
Our next focus will be how large-scale investors are participating in this stock of the Biotechnology Industry. The insider ownership of Jasper Therapeutics Inc is 8.34%, while institutional ownership is 58.73%. The most recent insider transaction that took place on Sep 22 ’25, was worth 99,630. In this transaction Director of this company bought 41,000 shares at a rate of $2.43, taking the stock ownership to the 41,000 shares. Before that another transaction happened on Sep 22 ’25, when Company’s Director bought 20,000 for $2.43, making the entire transaction worth $48,600. This insider now owns 20,000 shares in total.
Jasper Therapeutics Inc (JSPR) Earnings and Forecasts
In the latest quarterly report, which was put into the public domain on 12/31/2024, the organization reported -1.62 earnings per share (EPS), lower than consensus estimate (set at -1.23) by -0.39. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.68 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 13.33% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 23.05% during the next five years compared to 54.53% growth over the previous five years of trading.
Jasper Therapeutics Inc (NASDAQ: JSPR) Trading Performance Indicators
Take a look at Jasper Therapeutics Inc’s (JSPR) current performance indicators. Last quarter, stock had a quick ratio of 2.59.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -5.90, a number that is poised to hit -0.72 in the next quarter and is forecasted to reach -2.65 in one year’s time.
Technical Analysis of Jasper Therapeutics Inc (JSPR)
Compared to the last year’s volume of 0.47 million, its volume of 0.47 million showed improvement in the last five days. As of the previous 9 days, the stock’s Stochastic %D was 27.86%.
During the past 100 days, Jasper Therapeutics Inc’s (JSPR) raw stochastic average was set at 4.09%, which indicates a significant decrease from 23.96% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 0.1988 in the past 14 days, which was lower than the 0.2288 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $2.2928, while its 200-day Moving Average is $3.9922. Nevertheless, the first resistance level for the watch stands at $1.8700 in the near term. At $1.9500, the stock is likely to face the second major resistance level. The third major resistance level sits at $2.0700. If the price goes on to break the first support level at $1.6700, it is likely to go to the next support level at $1.5500. Should the price break the second support level, the third support level stands at $1.4700.
Jasper Therapeutics Inc (NASDAQ: JSPR) Key Stats
The company with the Market Capitalisation of 50.09 million has total of 16,253K Shares Outstanding. Its annual sales at the moment are 0 K in contrast with the sum of -71,270 K annual income. Company’s last quarter sales were recorded 0 K and last quarter income was -26,720 K.
